Randox Creatinine
Alkaline Picrate, Colorimetry, Creatinine. 510(k) K973993, from Randox Laboratories, Ltd. (Crumlin, IE). Product code CGX, class 2.
As of Nov 19, 2026, K973993 is an FDA 510(k) held by Randox Laboratories, Ltd., substantially equivalent on Mar 6, 1998 after 136 days, with no recalls tied to it in FDA's recall database.
- Review time: 136 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Randox Laboratories Limited Creatinine Test Kit is an in vitro diagnostic reagent for the quantitative determination of creatinine in human serum and plasma. The method is based on the reaction of creatinine with picrate in an alkaline environment (Jaffe) to produce a coloured complex. Creatinine is measured primarily to assess kidney function.
- Advia Chemistry Enzymatic Creatinine_2K070727 · Siemens Medical Solutions Diagnostics · Aug 3, 2007
- Tru Kidney Health Test Panel; Tru AnalyzerK251058 · Truvian Health · Nov 26, 2025
- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Creatinine2K210452 · Abbott Ireland Diagnostics Division · Mar 22, 2022
- Type
- Traditional
- Received
- Oct 21, 1997
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files